SSY Group (HKG:2005) obtained approval to produce and register its sodium acetate Ringer's and glucose injection from China's National Medical Products Administration after it passed the latter's consistency evaluation, a Thursday Hong Kong bourse filing said.
Sodium acetate Ringer's and glucose injection is mainly used in the supplement of extracellular fluid and the correction of metabolic acidosis when circulating blood volume and interstitial fluid are reduced, as well as in supplying energy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.